全國服務咨詢熱線：
18860915427
18860915427
產品分類
Product Category詳細介紹
| 品牌 | absin | CAS | 112522-64-2 |
|---|---|---|---|
| 分子式 | C15H15N3O2 | 純度 | ＞98% |
| 分子量 | 269.3 | 貨號 | abs810443 |
| 規格 | 5mg | 供貨周期 | 現貨 |
| 主要用途 | is an anti-cancer drug | 應用領域 | 化工,生物產業,農林牧漁,制藥/生物制藥,綜合 |
CI-994 112522-64-2
| 產品描述 | |
| 描述 | CI994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 μM. |
| 純度 | >98% |
| 儲存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 乙酰地那林；Acetyldinaline; Tacedinaline; PD 123654; Goe 5549 |
| 外觀 | off-white Powder |
| 可溶性/溶解性 | DMSO : 26.9 mg/mL (100 mM) |
| 生物活性 | |
| 靶點 | HDAC1 ,HDAC2 ,HDAC3 |
| In vitro(體外研究) | CI-994 ( CI-994 inhibits growth of LNCaP cell with IC50 of 7.4 μM. CI-994 exerts activity against several tumor cell lines with greater cytotoxicity against the solid tumors relative to both the leukemia and normal fibroblast cell lines. CI-994 inhibits growth of rat leukemia BCLO cells with IC50 of 2.5 μM. |
| In vivo(體內研究) | CI-994 exerts demonstrated antitumor activity against several tumor models, including the chemo-resistant mouse pancreatic ductal carcinoma as well as the human prostate tumor model LNCaP. |
| 研究領域 | |
| 研究領域 | CardiovascularHeartHypertrophyOther EpigeneticsChromatin Modifying EnzymesAcetylation EpigeneticsChromatin Modifying EnzymesAcetylationHDACsClass I Stem CellsSignaling PathwaysWntHDACs Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產品咨詢
電話
微信掃一掃
地址：上海市浦東新區新浩路58號申江科創園18棟
郵箱：fengmj@univ-bio.com
傳真：